5. 進行性核上性麻痺 Progressive supranuclear palsy Clinical trials / Disease details

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03625128 (ClinicalTrials.gov)	January 2, 2018	12/7/2018	18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Control ...	Phase 0 Evaluation of Clinical and Neuroimage (18F-PM-PBB3 PET) Study in Tauopathy Including Alzheim ...	Alzheimer's Disease;Cortical Basal Syndrome;Frontotemporal Dementia;Progressive Supranuclear Palsy;V ...	Drug: F-18	Chang Gung Memorial Hospital	NULL	Completed	20 Years	90 Years	All	36	Early Phase 1	Taiwan
2	EUCTR2017-000094-36-SE (EUCTR)	31/03/2017	30/01/2017	The BioFINDER 2 study - improved diagnostics and increased understanding of the underlying mechanism ...	The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of c ...	Neurodegenerative disorders with Tau-pathology; including, but not limited to, Alzheimers disease, p ...	Product Name: 18F-RO6958948 Trade Name: Vizamyl (flutemetamol(F-18)) Product Name: Vizamyl	Skåne University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Sweden
3	NCT02605785 (ClinicalTrials.gov)	November 2015	3/11/2015	A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy	A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy	Progressive Supranuclear Palsy	Drug: F-18 AV 1451	Mayo Clinic	NULL	Recruiting	35 Years	N/A	All	332	N/A	United States

First Previous1Next Last